Metformin as a safe and cost effective alternative to insulin in women with Diabetes in pregnancy.
dc.contributor.author | Isukapalli, Vani | |
dc.contributor.author | Radhika, M | |
dc.date.accessioned | 2015-10-17T09:05:49Z | |
dc.date.available | 2015-10-17T09:05:49Z | |
dc.date.issued | 2015-05 | |
dc.description.abstract | There is a substantial rise in diabetes complicating pregnancies in south Asian countries especialy India. Until many decades, insulin eras thought to be the only management option to maintain euglycemia in these cases. But metformin can be a safe and convenient alternative in such cases. In this background we have conducted a study I 40 women with diabetes complicating pregnancies and studied the outcome of the mother and neonate in important parameters. Metformin was found to be a safe, effective and cheap alternative to insulin therapy in pregnant diabetic women. | en_US |
dc.identifier.citation | Isukapalli Vani, Radhika M. Metformin as a safe and cost effective alternative to insulin in women with Diabetes in pregnancy. International Archives of Integrated Medicine. 2015 May; 2(5): 26-29. | en_US |
dc.identifier.issn | 2394-0026 (P) | |
dc.identifier.issn | 2394-0034 (O) | |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/164629 | |
dc.language.iso | en | en_US |
dc.source.uri | https://iaimjournal.com/wp-content/uploads/2015/05/5-Metformin-as-a-safe.pdf | en_US |
dc.subject | Gestational diabetes | en_US |
dc.subject | Insulin | en_US |
dc.subject | Type 2 diabetes | en_US |
dc.subject | Glycemic status | en_US |
dc.subject | Hypoglycemia | en_US |
dc.title | Metformin as a safe and cost effective alternative to insulin in women with Diabetes in pregnancy. | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- iaim2015v2n5p26.pdf
- Size:
- 98.48 KB
- Format:
- Adobe Portable Document Format
- Description:
- Original research article
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: